ARTICLE | Company News
Scolr Pharma, Dr. Reddy's deal
October 29, 2007 7:00 AM UTC
The companies partnered to develop and commercialize an undisclosed oral compound for cardiopulmonary indications. DDD will use its Controlled Delivery Technology (CDT) to formulate the compound and w...